Bleakley Financial Group LLC Cuts Position in Privia Health Group, Inc. $PRVA

Bleakley Financial Group LLC cut its stake in Privia Health Group, Inc. (NASDAQ:PRVAFree Report) by 4.3% in the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 16,560 shares of the company’s stock after selling 736 shares during the period. Bleakley Financial Group LLC’s holdings in Privia Health Group were worth $381,000 as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. CWM LLC grew its position in Privia Health Group by 50.3% in the first quarter. CWM LLC now owns 1,804 shares of the company’s stock worth $40,000 after acquiring an additional 604 shares in the last quarter. Bessemer Group Inc. grew its position in Privia Health Group by 2,393.4% in the first quarter. Bessemer Group Inc. now owns 2,269 shares of the company’s stock worth $51,000 after acquiring an additional 2,178 shares in the last quarter. Russell Investments Group Ltd. grew its position in Privia Health Group by 2,852.2% in the first quarter. Russell Investments Group Ltd. now owns 2,657 shares of the company’s stock worth $60,000 after acquiring an additional 2,567 shares in the last quarter. GAMMA Investing LLC grew its position in Privia Health Group by 113.1% in the first quarter. GAMMA Investing LLC now owns 2,866 shares of the company’s stock worth $64,000 after acquiring an additional 1,521 shares in the last quarter. Finally, Caitong International Asset Management Co. Ltd grew its position in Privia Health Group by 2,115.3% in the first quarter. Caitong International Asset Management Co. Ltd now owns 3,323 shares of the company’s stock worth $75,000 after acquiring an additional 3,173 shares in the last quarter. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research analysts recently issued reports on PRVA shares. Stephens reiterated an “overweight” rating and issued a $32.00 target price on shares of Privia Health Group in a research report on Wednesday, September 24th. Barclays lifted their price objective on Privia Health Group from $21.00 to $22.00 and gave the stock an “equal weight” rating in a report on Thursday, October 9th. Piper Sandler decreased their price objective on Privia Health Group from $36.00 to $35.00 and set an “overweight” rating on the stock in a report on Monday, August 11th. JMP Securities lifted their price objective on Privia Health Group from $29.00 to $30.00 and gave the stock a “market outperform” rating in a report on Friday, August 29th. Finally, Weiss Ratings reiterated a “sell (d+)” rating on shares of Privia Health Group in a report on Saturday. Eleven equities research analysts have rated the stock with a Buy rating, two have issued a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, Privia Health Group has an average rating of “Moderate Buy” and a consensus target price of $28.91.

Check Out Our Latest Research Report on PRVA

Privia Health Group Trading Up 0.4%

Shares of NASDAQ:PRVA opened at $25.99 on Monday. The company has a market cap of $3.19 billion, a price-to-earnings ratio of 236.29, a price-to-earnings-growth ratio of 3.55 and a beta of 0.83. The company has a 50-day moving average price of $23.52 and a 200-day moving average price of $22.68. Privia Health Group, Inc. has a 12 month low of $17.45 and a 12 month high of $26.49.

Privia Health Group (NASDAQ:PRVAGet Free Report) last issued its quarterly earnings data on Tuesday, June 7th. The company reported $0.10 EPS for the quarter. The firm had revenue of $213.61 million during the quarter. Privia Health Group had a net margin of 0.78% and a return on equity of 2.13%. As a group, research analysts forecast that Privia Health Group, Inc. will post 0.14 EPS for the current fiscal year.

Privia Health Group Company Profile

(Free Report)

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.

Featured Articles

Institutional Ownership by Quarter for Privia Health Group (NASDAQ:PRVA)

Receive News & Ratings for Privia Health Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Privia Health Group and related companies with MarketBeat.com's FREE daily email newsletter.